ChromaDex Pulls Challenged Tru Niagen Ad Claims
Executive Summary
After NAD attorneys asked for substantiation, ChromaDex “provided evidence supporting such claims which were not challenged” and stated it discontinued a challenged claim and testimonial.
You may also be interested in...
ChromaDex Business Blooms After Pulling Niagen Claims Under NAD Review
Since Council of Better Business Bureaus investigators in May 2018 asked about claims for Tru Niagen, ChromaDex pulled the ads while reaching milestones in product distribution and ingredient licensing.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
US Health And Wellness People News: CHPA, Bayer, Viatris, Qnovia, Powerade
Sanofi consumer health scientific affairs lead moves to CHPA; change in Bayer’s US consumer health marketing helm; Viatris CCO moves from same post at Moderna; Qnovia expands scientific advisory board; and Powerade powers Girls Inc. scholarships, programs.